Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Debt (2020 - 2026)

Journey Medical filings provide 6 years of Non-Current Debt readings, the most recent being $25.3 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 1.6% to $25.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.3 million, a 1.6% increase, with the full-year FY2025 number at $25.3 million, up 1.6% from a year prior.
  • Non-Current Debt hit $25.3 million in Q4 2025 for Journey Medical, up from $19.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $25.3 million in Q4 2025 to a low of $9.9 million in Q1 2023.
  • Median Non-Current Debt over the past 5 years was $19.7 million (2024), compared with a mean of $18.5 million.
  • Biggest five-year swings in Non-Current Debt: plummeted 32.81% in 2023 and later soared 70.15% in 2024.
  • Journey Medical's Non-Current Debt stood at $15.0 million in 2021, then surged by 32.42% to $19.8 million in 2022, then decreased by 26.25% to $14.6 million in 2023, then surged by 70.15% to $24.9 million in 2024, then increased by 1.6% to $25.3 million in 2025.
  • The last three reported values for Non-Current Debt were $25.3 million (Q4 2025), $19.5 million (Q3 2025), and $21.4 million (Q2 2025) per Business Quant data.